Usefulness of MCDA and examples
In this post we summarize its usefulness, the advantages and disadvantages, and we present two examples.
10 steps and tips on how to do an MCDA
There are many guidelines that teach you how to do an MCDA. Based on the guidelines available, and on the learnings we have been accumulating, here are the 10 steps you need to follow.
Multi Criteria Decision Analysis (MCDA)
Multi Criteria Decision Analysis (MCDA) is a tool to support decision making in health care. It complements other tools. It does not replace them.
The more complex the decisions, the more useful it will be.
Why? Because it is structured. It is multidisciplinary. It is transparent. It is systematic. And it incorporates several criteria. Hold your thoughts: we will come back to that.
Healixia Conference: Deep Dive into BeNeLuxA
On May 23rd , we joined the learning event about the BeNeLuxA initiative. https://www.healixia.be/meetings-detail-pagina/611/healixia-conference-deep-dive-into-beneluxa More about the BeNeLuxA initiative: https://beneluxa.org/collaboration
Innovation for Health – 2023
On 6 April 2023 at WTC Rotterdam, Vivactis Market Access attended the 10th edition of the leading conference for key players in Health & Life Sciences, Innovation for Health! The theme for this edition was Digital Transformation in Healthcare! https://hyphenprojects.nl/i4h/programme-overview
Press release: Weber joins Vivactis Group
Vivactis Group, the leading European healthcare consultancy group, announces its acquisition of Weber, a Market Access Consultancy firm and specialist in Health Economics and Outcomes Research (HEOR). The acquisition strengthens the Vivactis HM3A Market Access branch by expanding the reach in Market Access throughout Europe, as well as adding complementary HEOR and research science expertise.
European Health Summit 2022
Vivactis Market Access attended the the European Health Summit on December 8th in Brussels, Belgium.
The reimbursement pathway for digital mobile health applications in Belgium
The health app regulatory framework for financing of medical apps was announced in January 2021. This framework consists of a so-called ‘validation pyramid’ with 3 levels. Apps at level 3 are eligible for government funding.
Health Technology Assessment and a new EU Regulation – Part II
How and when will it impact your business?
Engage – by Pharma.be
Vivactis Market Access attended the the Engage networking event on November 24th in Brussels, Belgium. The event was organised by Pharma.be
Value Based Healthcare – by beMedTech
Vivactis Market Access attended the the Value Based Healthcare event on November 22nd in Brussels, Belgium. The event was organised by beMedTech with as topic ‘Geïntegreerde zorg: TO .be OR NOT TO .be’.
Science for Health – by MEDVIA
Vivactis Market Access attended the Science for Health event on November 21st in Brussels, Belgium. The event was organised by MEDVIA with as topic ‘Advancing Gene Therapy’.
Health Technology Assessment and a new EU Regulation – Part I
What are Health Technology Assessments? What is their purpose? Why does the new regulation matter?